Organisation paid for research Program year 2024 Source: CMS Open Payments

Columbia Nephrology Associates

Neither a doctor nor a teaching hospital

Research payments

$91,244

9 payments

Through program year 2024, Columbia Nephrology Associates is reported as receiving $91,244 in research payments, across 9 payments.

By program year

4 rows
Year Kind Amount Payments
2024 Research $76,487 2
2021 Research $8,300 3
2020 Research $498 1
2019 Research $5,959 3

Breakdown

Who paid Research payments · program years 2019–2024
  1. Biogen, Inc. $76,487 2 payments
  2. Alnylam Pharmaceuticals Inc. $8,798 4 payments
  3. Akebia Therapeutics Inc $5,959 3 payments
Studies the money was for Research payments · program years 2019–2024
  1. A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (FALCON) $56,649 1 payment
  2. An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (EAGLE) $19,837 1 payment
  3. A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) $8,300 3 payments
  4. Akb-6548-Ci-0015 $5,959 3 payments
  5. A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients With IgA Nephropathy $498 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record